A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in ...
Multiple myeloma, a cancer of the bone marrow, remains difficult to treat despite modern CAR T cell therapies. In recent research, a team led by Dr. Armin Rehm presents an improved immunotherapy that ...
Researchers have developed technologies that allow damaged proteins to be shredded or healthy ones installed. This may ...
Stage 1 multiple myeloma features low beta-2 microglobulin, high albumin, and no organ damage, often detected incidentally. Diagnosis involves blood, urine, imaging tests, and bone marrow biopsy to ...
Treatment for stage 3 myeloma is typically divided into phases. The goal is to achieve a deep remission, meaning the cancer ...
New immune roadmaps help physicians detect cancer recurrence early and customize treatments to the body’s defenses, providing ...
SurvivorNet on MSN
Cancer patients are living longer — a closer look at the treatments driving this progress
New data show cancer survival has reached a record high — nearly 70% of patients now live at least five years after diagnosis ...
While undergoing treatment for multiple myeloma, Rose Rose, of Jefferson Hills, Allegheny County, had to get infused with ...
Researchers at WashU Medicine and their collaborators have created an immune cell atlas of multiple myeloma, a cancer of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback